https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-revenue-tops-expectations-expects-return-sales-growth-2025-2023-11-02/
0
0
11/2/23 at 4:17pm
Organization
Reuters
Moderna <a href="https://www.reuters.com/markets/companies/MRNA.O" target="_blank">(MRNA.O)</a> on Thursday said its 2023 sales would only hit the low end of its $6 billion to $8 billion forecast, reflecting weaker demand for COVID-19 vaccines, and its shares…
Create an account
or login to join the discussion